Your telephone was most likely assembled in India. However was it constructed right here? That’s the query India’s electronics business is now making an attempt to reply. This additionally places three shares within the highlight – Kaynes Expertise, Dixon Applied sciences and Syrma SGS Expertise.
World brokerage Jefferies believes the federal government’s newest incentives may change the earnings alternative throughout the electronics manufacturing services (EMS) space, with element makers doubtlessly gaining an edge over assembly-focused corporations.
The brokerage has a ‘Purchase’ ranking on Kaynes Technology, whereas Dixon Applied sciences and Syrma SGS Expertise carry ‘Maintain’ scores.
Listed here are key particulars on which inventory the brokerage is preferring and the funding rationale behind it
From assembling telephones to creating elements
India’s electronics manufacturing has greater than doubled in 5 years, rising from round Rs 5.5 lakh crore in FY21 to Rs 12.1 lakh crore in FY26.
Cell phones account for almost half of this manufacturing. However home worth addition stays under 15%.
The brokerage home Jefferies in its report mentioned, “India is embarking on a stepwise method for indigenisation.”
The Cell Manufacturing-Linked Incentive (PLI) scheme, masking FY21-FY26, helped India assemble virtually 99% of cellphones domestically. Nonetheless, the brokerage believes the following part will focus extra on elements.
The Electronics Parts Manufacturing Scheme (ECMS) goals to construct this lacking provide chain.
ECMS may open a brand new alternative
Thus far, 106 tasks have been authorized underneath ECMS, in opposition to 249 preliminary purposes. Round 38 vegetation have already began manufacturing, whereas one other 16 tasks are at superior levels of development or equipment set up.
The authorized funding is round Rs 69,500 crore throughout 14 states.
Printed circuit boards (PCBs) may develop into one of many largest alternatives. Jefferies estimates the PCB market related to this chance at round $7 billion, with 85-90% presently depending on imports.
The brokerage expects ECMS to deal with round 50% of the cellular invoice of supplies (BoM) by the top of its six-year tenure.
It mentioned, “Choose Part performs vs. Meeting (DIXON).”
Why Kaynes will get the highest spot
Jefferies has a ‘Purchase’ ranking on Kaynes Expertise and prefers it over the opposite two shares.
The brokerage believes corporations concerned in elements may benefit extra as India will increase home sourcing.
Overseas know-how partnerships may additionally assist Indian corporations bridge present functionality gaps. Jefferies cited preparations reminiscent of Dixon-HKC and Syrma-Shinhyup as examples.
In its inventory desire, Jefferies mentioned, “We choose Part performs (KAYNES; Purchase; 55x 1-Y fwd) vs Meeting OEM (DIXON; Maintain; 67x).”
Dixon: Earlier beneficiary, new competitors forward?
Dixon Technologies stays carefully linked to India’s cellular manufacturing enlargement. The corporate was a key beneficiary of the sooner Giant-Scale Electronics Manufacturing (LSEM) PLI scheme.
However the brand new Cell Manufacturing Manufacturing Scheme (MPMS), additionally known as Cell 2.0, may convey extra competitors.
Jefferies expects cellular manufacturing to rise to round Rs 39 lakh crore underneath MPMS, in contrast with roughly Rs 25 lakh crore underneath the sooner scheme.
Nonetheless, the brokerage believes extra gamers may qualify this time.
It subsequently has a Maintain ranking on Dixon, with the inventory buying and selling at round 67 instances one-year ahead earnings.
Syrma SGS: Sturdy rally raises the bar
Jefferies has additionally assigned a ‘Maintain’ ranking to Syrma SGS Technology. The brokerage famous that the inventory has gained round 105% year-to-date, whereas buying and selling at about 57 instances one-year ahead earnings.
Jefferies mentioned, “we advocate prudence in Syrma (Maintain, 57x) publish +105% rally YTD.”
MPMS vs ECMS: What adjustments for buyers?
The 2 schemes goal completely different components of the electronics ecosystem.The Electronics Parts Manufacturing Scheme (ECMS) is geared toward growing home element manufacturing, whereas the Cell Manufacturing Manufacturing Scheme (MPMS) focuses extra on cellular manufacturing, exports and worth addition.
Jefferies estimates EMS corporations may ship a mean 27% CAGR in EPS between FY26-29. However execution will stay the important thing issue.
Disclaimer: This text is predicated on analysis studies from a number of brokerage companies and is for informational functions solely. The views, goal costs, and suggestions expressed are these of the respective brokerage companies and don’t replicate the official coverage or place of Monetary Specific. This shouldn’t be construed as a proposal, solicitation, or suggestion to purchase or promote securities. Traders should conduct their very own unbiased due diligence and search recommendation from a SEBI-registered monetary advisor earlier than making any funding choices.
